Financial News
Latest News about Pablo Zuanic
Recent news which mentions Pablo Zuanic
Aurora Cannabis: What Makes Upside Potential For This Pot Stock? Analyst Has An Idea
November 11, 2022
From Benzinga
Cannabis Earnings Are Flooding In: Here's An Analyst To Help You Digest Them, Four Companies For The Price Of One
November 10, 2022
From Benzinga
Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results
November 09, 2022
Tickers
CGC
From Benzinga
From Benzinga
WM Technology: Analyst Lowers Price Target To $5.00 But Stays Overweight
November 08, 2022
Tickers
MAPS
From Benzinga
Cantor Fitzgerald Lowers Price Target On Curaleaf Stock Post Q3 Earnings
November 08, 2022
Tickers
CURLF
From Benzinga
What Happens To Cannabis Bills If Republicans Take House And Senate? Here's One View
November 07, 2022
Tickers
CGC
From Benzinga
Forget About SAFE Plus Or CLIMB Act As Cannabis Stock Catalysts, With Canopy's Potential Exception
November 07, 2022
From Benzinga
Cresco Labs Gains 'Firm Visibility' With Recently Announced Asset Sales To Sean Diddy Combs
November 04, 2022
From Benzinga
Jushi Holdings Will Soon Announce 3Q, Analyst Puts Price Target At $2.25 And Maintains Neutral Rating
November 03, 2022
From Benzinga
Green Thumb Industries' Positive Q3 Report Compels Analyst To Place It Among 'Best-Managed MSOs'
November 03, 2022
From Benzinga
A Big If....Are Multinational Cannabis Companies Interested In Investing in South America?
November 03, 2022
From Benzinga
What's Going On With Recreational Cannabis Sales In Canada? Analyst Examines The Situation
October 31, 2022
From Benzinga
From Benzinga
Germany To Allow Adults To Possess An Ounce Of Cannabis And More In New Legalization Plan
October 26, 2022
From Benzinga
What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus
October 22, 2022
From Benzinga
Analysts Love These 5 Cannabis Stocks
October 20, 2022
From Benzinga
Aurora & Tilray Better Positioned Than Other Cannabis Operators For Germany's Imminent Market Launch, Here's Why
October 20, 2022
From Benzinga
As US Cannabis Sales Decline, This Analyst Predicts More Consolidation – Who Will Benefit?
October 18, 2022
From Benzinga
Another Marijuana Firm Dumps A NY Cannabis Deal: Analyst Reveals Future Acquisition Targets And Their M&A Outlook
October 17, 2022
From Benzinga
Tilray Stock Soars Then Returns To Earth On Biden's Cannabis Pardon News, This Analyst Remains Neutral
October 08, 2022
Tickers
TLRY
From Benzinga
Columbia Care: Updated Estimates Ahead Of Acquisition By Cresco Labs
October 07, 2022
Tickers
CCHWF
From Benzinga
Cannabis Share Prices Surge On Biden's Pardon For Weed Possession, Analyst's Insight On This Stock
October 07, 2022
From Benzinga
Biden's Pardon Could Help SAFE Plus, Cantor Fitzgerald Says: What Happens Now To Cannabis Stocks?
October 07, 2022
From Benzinga
Booker Comments On Biden Pardons: 'Now It's Time For Congress And States' To Take The Next Step
October 07, 2022
From Benzinga
New Poll: Majority Of U.S. Voters Support Federal Marijuana Legalization, But Do Politicians Care?
October 06, 2022
From Benzinga
From Benzinga
This Nutraceutical Company Stands To Become Leader In A Projected $50B Industry, New Analyst Insights
October 04, 2022
Tickers
IWINF
From Benzinga
This Analyst Makes The Case For Why There's Still Hope For A Cannabis Banking Reform Bill
September 26, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.